Article ; Online: Liver injury in the era of COVID-19.
World journal of gastroenterology
2021 Volume 27, Issue 5, Page(s) 377–390
Abstract: ... in those with a severe or critical illness. COVID-19 might provoke a deterioration of liver function in patients ... prolongs the hospital stay. In general, patients who develop liver dysfunction in COVID-19 are mainly males ... focuses on a possible relationship between COVID-19 and the liver, potential molecular mechanisms ...
Abstract | Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has undoubtedly revolutionized the whole globe and given a new point of view on respiratory tract infections. Nevertheless, coronavirus disease 2019 (COVID-19) cannot be perceived as a disease limited only to pneumonia with diverse severity. More and more reports have demonstrated a wide range of possible systemic symptoms, including hepatic complications. Liver injury has been observed in a significant proportion of patients, especially in those with a severe or critical illness. COVID-19 might provoke a deterioration of liver function in patients with already diagnosed chronic liver diseases and without pre-existing liver disorders. The deterioration of liver function worsens the prognosis, increases the risk of a severe course of SARS-CoV-2 infection and prolongs the hospital stay. In general, patients who develop liver dysfunction in COVID-19 are mainly males, elderly people, and those with higher body mass index. The underlying mechanisms for hepatic failure in patients infected with SARS-CoV-2 are still unclear, nevertheless liver damage appears to be directly connected with virus-induced cytopathic effects. A liver injury observed during hospitalization might be simultaneously caused by the use of potentially hepatotoxic drugs, mainly antiviral agents. This minireview focuses on a possible relationship between COVID-19 and the liver, potential molecular mechanisms of liver damage, the characteristics of liver injury and suggested factors predisposing to hepatic manifestations in COVID-19 patients. |
---|---|
MeSH term(s) | Antiviral Agents/adverse effects ; COVID-19/complications ; COVID-19/pathology ; COVID-19/physiopathology ; Gastrointestinal Tract/physiopathology ; Host-Pathogen Interactions ; Humans ; Inflammation/complications ; Liver/pathology ; Liver Failure/chemically induced ; Liver Failure/virology ; Metabolic Syndrome/complications ; Prognosis ; SARS-CoV-2/physiology ; COVID-19 Drug Treatment |
Chemical Substances | Antiviral Agents |
Language | English |
Publishing date | 2021-02-15 |
Publishing country | United States |
Document type | Journal Article ; Review |
ZDB-ID | 2185929-2 |
ISSN | 2219-2840 ; 1007-9327 |
ISSN (online) | 2219-2840 |
ISSN | 1007-9327 |
DOI | 10.3748/wjg.v27.i5.377 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6039: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.